4Oliva E, Clement PB, Young RH, et al. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopath ologic study of 15 cases. Am J Surg Pathol, 1998,22 (8):997~8.
5Oliva E, Young RH, Amin MB, et al. An immunohistochemi cal analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactity for individual antibodies. Am J Surg Pathol, 2002,26: 403 ~ 12.
6Chu P, Arber DA. Paraffin-section detection of CD10 in 505nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol, 2000,113: 374~82.
7Chu P, Arber DA, Weiss LM, et al. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumor: an immunohistochemical comparison of 34 cases. Mod Pathol, 2001,14:465~ 71.
8McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stromal and of endometrial stromal neoplasms.Histopathology, 2001,39: 273~8.
9Greaves MF, Brown G, Rapson NT, et al. Antisera to acute lymphoblastic leukemia cells. Clin Inmunol Imnunopathol,1975,4:67~84.
10Ordi J, Romagosa C, Tavassoli FA, et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract. A useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol, 2003,27(2) :178~6.